Veeva Systems Inc. $VEEV Holdings Cut by HF Advisory Group LLC

HF Advisory Group LLC lessened its holdings in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 58.4% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,395 shares of the technology company’s stock after selling 1,959 shares during the period. HF Advisory Group LLC’s holdings in Veeva Systems were worth $398,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in VEEV. Mirador Capital Partners LP boosted its position in shares of Veeva Systems by 10.3% during the 3rd quarter. Mirador Capital Partners LP now owns 5,958 shares of the technology company’s stock valued at $1,701,000 after acquiring an additional 556 shares during the last quarter. Riversedge Advisors LLC grew its holdings in shares of Veeva Systems by 13.7% during the third quarter. Riversedge Advisors LLC now owns 1,704 shares of the technology company’s stock worth $486,000 after purchasing an additional 205 shares in the last quarter. Wedmont Private Capital increased its position in shares of Veeva Systems by 12.0% in the third quarter. Wedmont Private Capital now owns 2,170 shares of the technology company’s stock worth $618,000 after purchasing an additional 232 shares during the last quarter. Vilga Financial Planning LLC bought a new position in shares of Veeva Systems in the third quarter worth approximately $1,713,000. Finally, LifeGoal Investments LLC purchased a new stake in Veeva Systems in the third quarter valued at approximately $259,000. Institutional investors own 88.20% of the company’s stock.

Wall Street Analyst Weigh In

VEEV has been the subject of several research analyst reports. Guggenheim lifted their target price on shares of Veeva Systems from $276.00 to $310.00 and gave the company a “buy” rating in a research report on Thursday, August 27th. Oppenheimer raised their price objective on shares of Veeva Systems from $225.00 to $300.00 and gave the company an “outperform” rating in a research report on Monday, August 17th. Barclays lifted their price objective on shares of Veeva Systems from $275.00 to $315.00 and gave the stock an “overweight” rating in a report on Thursday, August 27th. Needham & Company LLC upped their target price on shares of Veeva Systems from $270.00 to $310.00 and gave the stock a “buy” rating in a research report on Thursday, August 27th. Finally, Piper Sandler raised their price target on Veeva Systems from $295.00 to $320.00 and gave the company an “overweight” rating in a research report on Thursday, August 27th. Nineteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $284.88.

Read Our Latest Stock Analysis on Veeva Systems

Veeva Systems Stock Up 4.0%

Veeva Systems stock opened at $296.15 on Friday. The firm has a fifty day simple moving average of $261.01 and a two-hundred day simple moving average of $203.58. Veeva Systems Inc. has a twelve month low of $148.05 and a twelve month high of $302.17. The company has a market capitalization of $47.95 billion, a PE ratio of 48.71, a P/E/G ratio of 1.22 and a beta of 0.93.

Veeva Systems (NYSE:VEEV – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The technology company reported $2.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.23 by $0.12. The firm had revenue of $927.96 million for the quarter, compared to analysts’ expectations of $905.38 million. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%. The company’s revenue for the quarter was up 17.6% compared to the same quarter last year. During the same period last year, the firm earned $1.99 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. As a group, equities analysts expect that Veeva Systems Inc. will post 6.70 earnings per share for the current fiscal year.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

  • Positive Sentiment: Veeva’s strong second-quarter results, continued Vault CRM migrations and expansion of AI products support expectations for sustained growth. The company’s software remains deeply embedded in pharmaceutical and biotech workflows, creating customer retention and cross-selling opportunities. Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
  • Positive Sentiment: Veeva highlighted new AI capabilities, including Veeva Falcon and Vault AI, along with enhancements to its Development Cloud and Quality Cloud applications. These tools could increase the value of its platform as drug developers seek faster research, clinical-trial and quality processes. Veeva Systems Showcases AI Innovations
  • Positive Sentiment: Veeva Basics has reached nearly 200 customers and the company is drawing attention after reaching approximately 175 biotech customers, signaling adoption among emerging biopharma companies and a potentially broader long-term customer base. Veeva Basics Customer Update
  • Positive Sentiment: Market commentary identifies Veeva as one of the software companies benefiting from institutional buying after earlier fears that AI could make subscription software obsolete. Its sticky customer data and strong switching costs are viewed as competitive advantages. Wall Street Left Software for Dead
  • Neutral Sentiment: Evercore ISI raised its price target from $185 to $250, but that target is below the stock’s recent trading level, suggesting analysts may see less near-term upside after the rally. Evercore ISI Adjusts Veeva Price Target
  • Negative Sentiment: Investors remain concerned that market saturation could limit growth, while valuation-focused analysis estimates the shares may be roughly 11% above fair value based on future cash generation. Veeva’s sharp advance also leaves the stock vulnerable to profit-taking if adoption or earnings momentum slows. Veeva Stock May Be Below Fair Value

Insider Buying and Selling

In other news, EVP Daniel J. Rizzo sold 4,841 shares of the stock in a transaction that occurred on Friday, October 2nd. The stock was sold at an average price of $276.51, for a total transaction of $1,338,584.91. Following the completion of the sale, the executive vice president owned 7,665 shares of the company’s stock, valued at approximately $2,119,449.15. This represents a 38.71% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Priscilla Hung sold 750 shares of the firm’s stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $261.04, for a total transaction of $195,780.00. Following the completion of the transaction, the director owned 3,242 shares in the company, valued at $846,291.68. This represents a 18.79% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 51,591 shares of company stock worth $13,355,945 in the last ninety days. 10.60% of the stock is owned by insiders.

About Veeva Systems

(Free Report)

Veeva Systems Inc is a cloud software company that provides applications and services for the life sciences industry. Its customers include pharmaceutical, biotechnology, medical device and other organizations involved in developing, manufacturing and commercializing regulated products.

The company’s product portfolio includes the Veeva Vault platform, which supports areas such as clinical operations, regulatory affairs, quality management, safety and medical communications. Veeva also offers commercial and customer relationship management applications, data and analytics products, and services designed to help life sciences companies manage relationships with healthcare professionals, oversee content and improve operational efficiency.

Founded in 2007, Veeva serves customers globally and has expanded its offerings from commercial software into research, development, manufacturing and quality processes.

Read More

Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).

Institutional Ownership by Quarter for Veeva Systems (NYSE:VEEV)

Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.